Pediatric ED Length of Stay Reduced With Observation Unit for Mental Health
By Elana Gotkine HealthDay Reporter
MONDAY, May 6, 2024 -- Children with mental health emergencies presenting to the pediatric emergency department (PED) who receive psychiatric comanagement in a pediatric observation unit (POU) have significantly reduced PED length of stay (LOS) and inpatient psychiatric (IP) admission, according to a research letter published online May 5 in JAMA Pediatrics to coincide with the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.
Rachel G. Kasdin, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined outcomes of children admitted for mental health emergencies who received psychiatric comanagement in a POU using data from two PEDs between Jan. 1 and Dec. 31, 2022. One site had a separate POU with dedicated staff following a psychiatric comanagement model, while the comparison site only had social work available. Admission decisions could be reversed by the POU comanagement team or the PED clinician at the PED-only site.
Overall, 88 and 82 patients from the PED and POU site and the PED-only site, respectively, were included. The researchers found that the PED LOS was 3.5 and 10.1 hours in the PED and POU site and the PED-only site, respectively. No difference was seen between the sites in the IP LOS or total treatment time. Forty-eight percent of the PED and POU patients had their admission decision reversed and were discharged compared with no reversals in the PED-only group. Patients from PED and POU were less likely to complete admission to IP (unadjusted odds ratio, 1.9).
"Psychiatric comanagement in a POU may decrease the burden of care in the PED and reduce demand for inpatient resources for children with psychiatric emergencies," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.